Baim Institute for Clinical Research
28
0
0
19
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
14.3%
4 terminated/withdrawn out of 28 trials
82.6%
-3.9% vs industry average
21%
6 trials in Phase 3/4
68%
13 of 19 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (28)
NORM-HF Pivotal Study
Role: collaborator
Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial
Role: lead
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
Role: collaborator
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Role: collaborator
Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation
Role: lead
Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure
Role: collaborator
Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography
Role: collaborator
Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.
Role: collaborator
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Role: lead
Correlation of SOZO BIS Measures With CardioMEMS PA Pressure
Role: collaborator
Early Alirocumab to Reduce LDL-C in Myocardial Infarction
Role: collaborator
Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac Artery
Role: collaborator
Diagnosing Respiratory Disease in Children Using Cough Sounds 2
Role: collaborator
Clinical Study of INFUSE® Bone Graft Compared to Autogenous Bone Graft for Vertical Ridge Augmentation
Role: collaborator
Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)
Role: collaborator
The Dual Antiplatelet Therapy Study (DAPT Study)
Role: lead
The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
Role: collaborator
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Role: collaborator
Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA)
Role: collaborator
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Role: collaborator